CS
CRTX

Credit Suisse’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

Credit Suisse’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-22,665
Closed -$216K – 5006
2013
Q4 		$216K Buy
+22,665
New +$215K ﹤0.01% 4288

Other funds holding CRTX

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Credit Suisse's CRTX Position: Q1 2014 in Review

Credit Suisse sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 22,665 shares — an estimated $216K sold.

Credit Suisse first reported a position in CRTX in Q4 2013 and held it in 1 quarter. The position peaked at $216K in Q4 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • Credit Suisse reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • Credit Suisse sold 22,665 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $216K.
  • Credit Suisse first reported a position in CORNERSTONE THERAPEUTICS INC in Q4 2013 and held it in 1 quarter.
  • Credit Suisse's CORNERSTONE THERAPEUTICS INC position peaked at $216K in Q4 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on Credit Suisse's 13F filing for Q1 2014, filed 15 May 2014.